| The metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer CP Capper, JM Rae, RJ Auchus Hormones and cancer 7, 149-164, 2016 | 92 | 2016 |
| Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through Missplicing A Maharaj, F Buonocore, E Meimaridou, G Ruiz-Babot, L Guasti, ... Journal of the Endocrine Society 3 (1), 201-221, 2019 | 38 | 2019 |
| The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer CP Capper, JM Larios, MJ Sikora, MD Johnson, JM Rae Breast cancer research and treatment 157, 23-30, 2016 | 17 | 2016 |
| A high rate of novel CYP11B1 mutations in Saudi Arabia AS Alzahrani, MM Alswailem, AK Murugan, DS Alhomaidah, CP Capper, ... The Journal of Steroid Biochemistry and Molecular Biology 174, 217-224, 2017 | 6 | 2017 |
| Functional characterization of the G162R and D216H genetic variants of human CYP17A1 CP Capper, J Liu, LR McIntosh, JM Larios, MD Johnson, PF Hollenberg, ... The Journal of steroid biochemistry and molecular biology 178, 159-166, 2018 | 2 | 2018 |
| CYP17A1 and abiraterone: Implications for breast cancer endocrine therapy CP Capper, MD Johnson, JM Larios, JM Rae Cancer Research 74 (19_Supplement), 5568-5568, 2014 | 1 | 2014 |
| Predicted benign and silent SNPs in CYP11A1 cause primary adrenal insufficiency through missplicing A Maharaj, F Buonocore, E Meimaridou, G Ruiz-Babot, L Guasti, ... Endocrine Abstracts 50, 2017 | | 2017 |
| ALDOSTERONE SYNTHASE DEFICIENCY IN TWO UNRELATED LEBANESE CHILDREN C Ghaddhab, CP Capper, W Fayad, P Olivier, G Van Vliet, RJ Auchus, ... HORMONE RESEARCH IN PAEDIATRICS 88, 76-77, 2017 | | 2017 |
| Functional Characterization of Cytochrome P450 17A1 (CYP17A1) Gene Variants for their Steroidogenic Enzymatic Activities. CP Capper | | 2016 |
| Using a cell based model system to characterize CYP17A1 genetic variants CP Capper, J Liu, L McIntosh, JM Larios, MD Johnson, PF Hollenberg, ... Cancer Research 75 (15_Supplement), 1863-1863, 2015 | | 2015 |
